Evidence map›Paper›PMID 36342155›Full record

ArticleAntimicrobial agents and chemotherapy2022

First Detection of Mycobacterium tuberculosis Clinical Isolates Harboring I491F Borderline Resistance

Aye Su Mon, Phyu Win Ei, Mi Mi Htwe, Myat Htut Nyunt, Su Mon Win, Wint Wint Nyunt, Zaw Myint, Wah Wah Aung

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. First detection of aEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aye Su MonAdvanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar.
Phyu Win EiAdvanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar.
Mi Mi HtweAdvanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar.
Myat Htut NyuntAdvanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar.
Su Mon WinAdvanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar.
Wint Wint NyuntNational TB Reference Laboratory, Aung San, Yangon, Myanmar.
Zaw MyintNational Tuberculosis Program (Yangon Branch), Department of Public Health, Yangon, Myanmar.
Wah Wah AungAdvanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar.ORCID 0000-0002-5780-4961

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibiotics, AntitubercularMycobacterium tuberculosisAntitubercular AgentsBacterial ProteinsDNA-Directed RNA PolymerasesDrug Resistance, BacterialMutationMyanmarAntibiotics, AntitubercularAntitubercular AgentsBacterial ProteinsDNA-Directed RNA PolymerasesI491FMyanmarMycobacterium tuberculosisrifampin resistance

Identifiers

PMID36342155
PMCPMC9765286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.